Midday movers: Kate Spade, Apple, Hospira & more

NYSE New York Stock Exchange
Scott Mlyn | CNBC

Take a look at some of Thursday's midday movers:

Kate Spade - The handbag-and-fashion retailer jumped after reporting a 30 percent rise in quarterly sales and hiking its 2014 guidance.

Genworth Financial - The insurance company plunged after posting huge quarterly loss.

AES - The utility fell after tallying third-quarter revenue below expectations. Competitor Ameren also dropped after reporting quarterly results short of estimates, as did Entergy. Northeast Utilities declined ahead of its earnings report after the close.

Cott - The Canadian beverage maker rose after saying it would buy DSS Group in a deal valued at around $1.25 billion to expand into water and coffee delivery.

Allergan - The Botox maker rose after saying it's in merger discussions with an unidentified company as it tries to tend off a hostile takeover by Valeant Pharmaceuticals.

Apple - The consumer-technology company edged lower after saying it had identified and blocked malicious software applications targeting users in China.

BroadSoft - The telecom-software company climbed after Raymond James raised its rating to a strong buy.

Ann - The clothing-chain operator gained after lowering its full-year sales outlook.

Petrobras - The Brazilian energy company fell after saying it has no set date or amount for its expected fuel price hike.

Prudential Financial - The life insurer dropped after posting weaker-than-expected quarterly profits.

Orbitz Worldwide - The online travel site declined after posting weaker-than-expected quarterly profit.

Hospira - The maker of drugs that can be injected gained after posting better-than-expected quarterly earnings.

AMC Networks - The television network rose after reporting a better-than-estimated quarterly profit.

Tableau Software - The maker of data-analytics software rose after delivering third-quarter revenue and profit that beat estimates.

Costco Wholesale - The discount-warehouse chain climbed after reporting sales at stores open at least a year increased four percent in October.

Aeterna Zentaris - The biopharmaceutical company tanked after after the Food and Drug Administration rejected its growth hormone test.

Aegerion Pharmaceuticals - The drug developer jumped on plans to buy a treatment for a rare disease from AstraZeneca.

(See CNBC's Market Insider Blog)

Questions? Comments? Email us at marketinsider@cnbc.com